Stemtech (STEK) Invested Capital (2012 - 2025)
Stemtech's (STEK) quarterly Invested Capital came in at -$3.5 million in Q4 2025, down 151.0% year-on-year from $6.9 million in Q4 2024, and down 111.07% quarter-over-quarter from -$1.7 million in Q3 2025.
Stemtech (STEK) Invested Capital (2012 - 2025) Analysis & Trends
Stemtech has disclosed Invested Capital across 14 years of filings, most recently posting -$3.5 million for Q4 2025.
- Invested Capital for Q4 2025 came in at -$3.5 million, down 151.0% year-over-year; the trailing twelve-month figure through Dec 2025 was -$3.5 million (down 151.0% YoY), and the FY2025 annual result was -$3.5 million, down 151.0% from the prior year.
- Invested Capital came in at -$3.5 million for Q4 2025 at Stemtech, down from -$1.7 million in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $896097.0 in Q1 2021 to a low of -$3.5 million in Q4 2025.
- The 5-year median for Invested Capital is -$1.3 million (2022), against an average of -$1.1 million.
- Across the five-year window, Invested Capital jumped 255.74% in 2023 and slumped 1194.5% in 2024, its largest moves.
- Stemtech's Invested Capital stood at $219139.0 in 2021, then plunged by 307.3% to -$454285.0 in 2022, then surged by 255.74% to $707516.0 in 2023, then plunged by 299.46% to -$1.4 million in 2024, then plunged by 151.0% to -$3.5 million in 2025.
- The last three Invested Capital figures came in at -$3.5 million (Q4 2025), -$1.7 million (Q3 2025), and -$1.6 million (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.97 Bn | 36.23 Bn | 1.97 Bn | 10.84 Bn |
| 2 | Zoetis | 33.59 Bn | 31.65 Bn | 1.62 Bn | 3.23 Bn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 5.90 Bn |
| 4 | Neurocrine Biosciences | 16.10 Bn | 14.78 Bn | 800.70 Mn | 3.41 Bn |
| 5 | Aurora Cannabis | 15.56 Bn | 15.47 Bn | 21.72 Mn | 373.23 Mn |
| 6 | Elanco Animal Health | 12.04 Bn | 11.61 Bn | 785.00 Mn | 10.24 Bn |
| 7 | Alkermes | 7.36 Bn | 6.84 Bn | -116.06 Mn | 1.78 Bn |
| 8 | Lantheus Holdings | 6.74 Bn | 6.24 Bn | 230.92 Mn | 1.79 Bn |
| 9 | Liquidia | 6.27 Bn | 6.04 Bn | 121.79 Mn | 108.58 Mn |
| 10 | Stemtech | - | - | 354,677.00 | -3.54 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -3.54 Mn |
| Sep 30, 2025 | -1.68 Mn |
| Jun 30, 2025 | -1.57 Mn |
| Mar 31, 2025 | -1.52 Mn |
| Dec 31, 2024 | -1.41 Mn |
| Jun 30, 2024 | -2.25 Mn |
| Mar 31, 2024 | -2.51 Mn |
| Dec 31, 2023 | 707,516.00 |
| Sep 30, 2023 | 436,138.00 |
| Jun 30, 2023 | -2.63 Mn |
| Mar 31, 2023 | -193,614.00 |
| Dec 31, 2022 | -454,285.00 |
| Sep 30, 2022 | -1.28 Mn |
| Jun 30, 2022 | -1.16 Mn |
| Mar 31, 2022 | -584,766.00 |
| Dec 31, 2021 | 219,139.00 |
| Sep 30, 2021 | -2.34 Mn |
| Jun 30, 2021 | -247,927.00 |
| Mar 31, 2021 | 896,097.00 |
| Nov 30, 2020 | -231,943.00 |